Cellsonics Inc.

📍 San Jose, United States🗓 Founded 2017👥 10 employees💰 Last funded Mar 2022
Biotechnology Research🌐 cellsonics.com
Website LinkedIn
Cellsonics has re-engineered single cell sample preparation to capture the full potential of each and every tissue specimen. The innovative SimpleFlow tissue dissociation system enables researchers to capture important single cells with a user- and cell-friendly method. With the SimpleFlow system - Maintain the native gene expression profile across tissue and cell types. - Recover the full spectrum of heterogeneous cell populations from solid tissue samples in 4-12 minutes of hands-free processing. - Dissociate samples in cold temperatures without the use of enzymes preserving sample integrity throughout the process. - Load solid tissue sample into disposable self-contained SimpleFlow cartridge, load into SimpleFlow instrument, select protocol that minces tissue, dissociates and then filters cells that are recovered in a detachable tube for downstream processes. Want more information? Visit our website at www.cellsonics.com to learn more and set up a SimpleFlow demo using the website Contact link.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Cellsonics Inc.?
Cellsonics Inc. has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Cellsonics Inc. last raise funding?
The most recent investment in Cellsonics Inc. recorded on gritt.io was in March 2022.
When was Cellsonics Inc. founded?
Cellsonics Inc. was founded in 2017.
What industry is Cellsonics Inc. in?
Cellsonics Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Cellsonics Inc. based?
Cellsonics Inc. is headquartered in San Jose, United States.